Investors with the goal of beating the broader market often turn to stock selection. Strategic choices in individual stocks can have a profound impact on your wealth.
The price of Staar Surgical Co (NASDAQ: STAA) closed at $24.13 in the last session, down -2.23% from day before closing price of $24.68. In other words, the price has decreased by -$2.23 from its previous closing price. On the day, 1.97 million shares were traded. STAA stock price reached its highest trading level at $24.54 during the session, while it also had its lowest trading level at $23.03.
Ratios:
We take a closer look at STAA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 4.35 and its Current Ratio is at 5.21. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.10.
Upgrades & Downgrades
In the most recent recommendation for this company, Wells Fargo on April 21, 2025, initiated with a Equal Weight rating and assigned the stock a target price of $17.
Mizuho Downgraded its Outperform to Neutral on February 12, 2025, whereas the target price for the stock was revised from $45 to $17.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Nov 21 ’25 when BROADWOOD PARTNERS, L.P. bought 797,486 shares for $27.86 per share. The transaction valued at 22,218,837 led to the insider holds 15,019,491 shares of the business.
BROADWOOD PARTNERS, L.P. bought 393,382 shares of STAA for $10,675,325 on Nov 20 ’25. The 10% Owner now owns 14,222,005 shares after completing the transaction at $27.14 per share. On Nov 19 ’25, another insider, BROADWOOD PARTNERS, L.P., who serves as the 10% Owner of the company, bought 309,132 shares for $26.42 each. As a result, the insider paid 8,166,155 and bolstered with 13,828,623 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, STAA now has a Market Capitalization of 1191200384 and an Enterprise Value of 1046730304. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 3.74. For the stock, the TTM Price-to-Sale (P/S) ratio is 5.21 while its Price-to-Book (P/B) ratio in mrq is 3.37. Its current Enterprise Value per Revenue stands at 4.539 whereas that against EBITDA is -19.386.
Stock Price History:
The Beta on a monthly basis for STAA is 1.00, which has changed by 0.031341434 over the last 52 weeks, in comparison to a change of 0.13613915 over the same period for the S&P500. Over the past 52 weeks, STAA has reached a high of $30.81, while it has fallen to a 52-week low of $13.50. The 50-Day Moving Average of the stock is -7.67%, while the 200-Day Moving Average is calculated to be 10.37%.
Shares Statistics:
According to the various share statistics, STAA traded on average about 1.08M shares per day over the past 3-months and 1496200 shares per day over the past 10 days. A total of 49.35M shares are outstanding, with a floating share count of 49.35M. Insiders hold about 0.79% of the company’s shares, while institutions hold 106.03% stake in the company. Shares short for STAA as of 1764288000 were 3982615 with a Short Ratio of 3.70, compared to 1761868800 on 3862458. Therefore, it implies a Short% of Shares Outstanding of 3982615 and a Short% of Float of 14.08.
Earnings Estimates
As of right now, 5.0 analysts gave their recommendation on the stock of the company. The consensus estimate for the next quarter is $0.03, with high estimates of $0.13 and low estimates of -$0.21.
Analysts are recommending an EPS of between $0.14 and -$0.06 for the fiscal current year, implying an average EPS of $0.01. EPS for the following year is $0.37, with 6.0 analysts recommending between $0.78 and -$0.23.
Revenue Estimates
According to 6 analysts,. The current quarter’s revenue is expected to be $75.55M. It ranges from a high estimate of $78.3M to a low estimate of $72.98M. As of. The current estimate, Staar Surgical Co’s year-ago sales were $48.95MFor the next quarter, 6 analysts are estimating revenue of $71.99M. There is a high estimate of $79.1M for the next quarter, whereas the lowest estimate is $60.7M.
A total of 8 analysts have provided revenue estimates for STAA’s current fiscal year. The highest revenue estimate was $264.18M, while the lowest revenue estimate was $254.6M, resulting in an average revenue estimate of $258.1M. In the same quarter a year ago, actual revenue was $313.9MBased on 11 analysts’ estimates, the company’s revenue will be $312.29M in the next fiscal year. The high estimate is $344.5M and the low estimate is $271M.
